Trial Profile
A phase I trial of EVT 401 in healthy male subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 21 Jan 2020
Price :
$35
*
At a glance
- Drugs EVT 401 (Primary)
- Indications Chronic obstructive pulmonary disease; Irritable bowel syndrome; Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors Evotec AG; Evotec SE
- 29 Jun 2009 Status changed from active, no longer recruiting to completed, according to an Evotec media release.
- 13 Oct 2008 New trial record.